bioRxivPathologyPreprint
Prospective evaluation of renal function in dogs with chronic mitral valve disease
E. Martinelli, S. Crosara, C. Locatelli, A. M. Zanaboni, P. Brambilla, C. Quintavalla
Abstract
The coexistence of renal and cardiac disease has been defined in dogs and cats as cardiovascular-renal disorders (CvRD). In humans, renal function is affected by recurrent episodes of acute congestive heart failure (CHF). The aim of this prospective, case-control study was to evaluate the appearance and influence of worsening cardiac disease (WCD), defined on echocardiographic and radiographic parameters, on renal function (defined as worsening renal function [WRF], on the basis of serum creatinine level and presence of proteinuria) in two population: 21 dogs with chronic mitral valve disease (CMVD) and 20 healthy dogs. Dogs were sorted into groups according to the presence/absence of WRF or WCD. Statistical analysis was performed between CMVD dogs and healthy dogs and inside the CMVD dogs group. There was no statistically significant difference in developing WRF between dogs with/without WCD and no statistical evidence to support a difference in WRF parameters in dogs experiencing CHF and dogs not experiencing it. The prevalence of azotemia in CMVD dogs was significantly higher than the prevalence of azotemia previously reported in the general population of dogs. Diuretics therapy didnt affect renal function. No difference in survival time was seen between groups. In conclusion, CHF, WCD and diuretics therapy didnt directly induce WRF. However, considering the prevalence of azotemia, data suggests a link between heart and kidney function (despite we didnt excluded aged-related coexistence of organ damage). A bigger number of dogs at inclusion is required to reach statistical significance.
- assay: clinical cohort / trial
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Altered systemic bioenergetic reserve in chronic kidney disease predisposes hearts to worse functional outcomes
Megan Young, Malene Aastrup, … Dunja Aksentijević·Scientific ReportsPeer-reviewed·Nov 21, 2025
- Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols
M. BAGARDI, C. Locatelli, … P. G. Brambilla·bioRxiv·Jan 13, 2020
- Elevated blood creatinine -a biomarker of renal function- associates with multiple metabolic perturbations in dogs
Claudia Ottka, Katariina Vapalahti, … Hannes Lohi·bioRxiv·May 6, 2020
- IL-17A Mediates Cardiac Hypertrophy in Chronic Kidney Disease through the IL-23/Th17 Axis.
Fumihiko Ogata, Shinsuke Hanatani, … Kenichi Tsujita·bioRxiv·Sep 23, 2026
- Myocardin ablation in a cardiac-renal rat model
Anupam Mittal, Santanu Rana, … Madhu Khullar·Scientific ReportsPeer-reviewed·Apr 10, 2019
- Effectiveness of Growth Hormone Releasing Hormone Agonists (GHRH A) in Chronic Kidney Disease Induced Heart Failure with Preserved Ejection Fraction
A. C. Rieger, L. L. Bagno, … J. M. Hare·bioRxiv·May 30, 2020